By otakuyassine3@gmail.com 
Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) gapped up prior to trading on Monday . The stock had previously closed at $26.20, but opened at $26.93. Hims & Hers Health shares last traded at $26.24, with a volume of 3,075,345 shares.
Analyst Ratings Changes
Several analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft lifted their price objective on Hims & Hers Health from $23.00 to $27.00 and gave the company a “hold” rating in a research report on Wednesday, November 6th. Piper Sandler reiterated a “neutral” rating and issued a $21.00 price objective (up previously from $18.00) on shares of Hims & Hers Health in a report on Tuesday, November 5th. Morgan Stanley assumed coverage on Hims & Hers Health in a research report on Tuesday, December 17th. They set an “overweight” rating and a $42.00 price objective for the company. Canaccord Genuity Group increased their price target on shares of Hims & Hers Health from $28.00 to $38.00 and gave the stock a “buy” rating in a research note on Monday, December 2nd. Finally, TD Cowen reissued a “buy” rating and set a $28.00 price objective on shares of Hims & Hers Health in a research note on Wednesday, November 20th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $22.80.
View Our Latest Stock Report on Hims & Hers Health
Hims & Hers Health Trading Up 4.2 %
The stock has a 50 day simple moving average of $25.78 and a 200-day simple moving average of $21.26. The firm has a market cap of $5.96 billion, a PE ratio of 62.02 and a beta of 1.25.
Hims & Hers Health (NYSE:HIMS – Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.06 by $0.26. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. The company had revenue of $401.56 million for the quarter, compared to analysts’ expectations of $382.20 million. During the same period in the previous year, the firm earned ($0.04) EPS. The firm’s revenue was up 77.1% compared to the same quarter last year. On average, equities research analysts expect that Hims & Hers Health, Inc. will post 0.29 EPS for the current year.
Insiders Place Their Bets
In related news, CEO Andrew Dudum sold 78,127 shares of the company’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $29.62, for a total transaction of $2,314,121.74. Following the transaction, the chief executive officer now directly owns 109,956 shares in the company, valued at approximately $3,256,896.72. This represents a 41.54 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Oluyemi Okupe sold 269,739 shares of the stock in a transaction that occurred on Monday, October 14th. The stock was sold at an average price of $20.31, for a total value of $5,478,399.09. Following the completion of the sale, the chief financial officer now owns 145,763 shares in the company, valued at approximately $2,960,446.53. The trade was a 64.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,085,157 shares of company stock valued at $26,765,193 in the last quarter. 17.71% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Hims & Hers Health
Several institutional investors have recently made changes to their positions in HIMS. Nisa Investment Advisors LLC grew its holdings in Hims & Hers Health by 679.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,839 shares of the company’s stock worth $37,000 after acquiring an additional 1,603 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in Hims & Hers Health by 67.5% during the second quarter. Bank of New York Mellon Corp now owns 678,602 shares of the company’s stock valued at $13,701,000 after buying an additional 273,473 shares during the period. State of Michigan Retirement System raised its stake in Hims & Hers Health by 177.8% in the second quarter. State of Michigan Retirement System now owns 500,000 shares of the company’s stock worth $10,095,000 after buying an additional 320,000 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in Hims & Hers Health by 322.9% during the second quarter. Allspring Global Investments Holdings LLC now owns 52,312 shares of the company’s stock worth $1,056,000 after buying an additional 39,943 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Hims & Hers Health by 33.0% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 27,830 shares of the company’s stock valued at $562,000 after acquiring an additional 6,912 shares during the period. Hedge funds and other institutional investors own 63.52% of the company’s stock.
Hims & Hers Health Company Profile
Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
Featured Stories
Receive News & Ratings for Hims & Hers Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Hims & Hers Health and related companies with MarketBeat.com’s FREE daily email newsletter.